FindTrial
Sign In

Study on postoperative analgesia effect of lidocaine patient-controlled intravenous analgesia in patients undergoing laparoscopic colorectal tumor surgery

Study on postoperative analgesia effect of lidocaine patient-controlled intravenous analgesia in patients undergoing laparoscopic colorectal tumor surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068854
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal tumor

Interventions

Experimental group :PCIA: lidocaine 72mg/kg and normal saline are made into 300lm.
Control group:PCIA: sufentanil 2µg/kg and normal saline are made into 300lm.

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.The age is 18~65 years old. 2.BMI 18-28 kg/m2. 3.ASA grade ? ~ ?.

Exclusion criteria

Exclusion criteria: 1.Heart rate < 50 beats/min, or suffering from severe heart block. 2.Hepatic and renal insufficiency. 3.The cardiac function is grade 3-4. 4.Uncontrolled hypertension. 5.History of lidocaine allergy. 6.Neuropsychiatric disorder.

Design outcomes

Primary

MeasureTime frame
Analgesic effect;—

Secondary

MeasureTime frame
Inflammatory factor;PCIA press times, effective press times;Incidence of postoperative salvage analgesia;Patient recovery quality score (Qor-15 scale);PONV incidence;Incidence of remedial antiemesis;Incidence rate of local anesthetic poisoning;Blood concentration of lidocaine;—

Countries

China

Contacts

Public ContactYan Wenjun

Gansu Provincial Hospital

871523533@qq.com+86 138 9337 0700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026